Answers are grounded in this paper and cite their sources.
BACKGROUND: The present study aimed to investigate whether newly defined serum uric acid (SUA) to serum creatinine ratio (SUA/SCr) predicts no-reflow phenomenon (NRP) development in patients with non-ST-elevated acute coronary syndrome (NSTE-ACS). METHODS: The study group was divided into two groups: those who developed NRP and those who did not. Complete blood counts, SUA, serum creatinine, C-reactive protein (CRP) and albumin were obtained at admission. The SUA/SCr, SUA to albumin ratio (UAR), C-reactive protein to albumin ratio (CAR) and systemic immune inflammation (SII) index values of all patients were calculated and their relationships with NRP were evaluated. A SUA/SCr ratio ≥5.34 predicted the NRP with 75% sensitivity and 55% specificity. CONCLUSION: SUA/SCr ratio can be used as a reliable marker in prediction the development of NRP in NSTE-ACS patients.
No takes yet. Share an insight, caveat, or question.
Kalyoncuoğlu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: